Clin2
NCT06898203Possibly a fitRecruiting

Precision imaging for Kaposi sarcoma

Kaposi Sarcoma

Part of Cancer, Infections clinical trials.

This trial uses advanced imaging to better understand Kaposi sarcoma. If you are starting or already receiving treatment, researchers want to see how imaging can help track your cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have Kaposi sarcoma confirmed by a biopsy and at least 3 skin lesions.
  • You are able to understand and agree to the study.
  • If you are in Aim 2, you must already be on Kaposi sarcoma treatment.
  • If you are in Aim 3, you must be starting Kaposi sarcoma treatment for the first time.
  • You cannot be very ill and need hospitalization (for Aim 2) or have had prior treatment (for Aim 3).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06751355Recruiting
Precision imaging for Kaposi sarcoma

This trial tests a special imaging device to see if it can better evaluate Kaposi sarcoma skin lesions. It may help doctors understand the extent of the disease without relying only on physical exams.

St Louis, Missouri
NCT06375122Recruiting
A study of Kaposi sarcoma over time

This study follows people with Kaposi sarcoma to learn more about the disease and how it changes over time. It may help doctors better understand and treat KS in the future.

Bethesda, Maryland
NCT04303117Recruiting· Phase 1/Phase 2
Test drug PDS01ADC alone and with immunotherapy for Kaposi sarcoma

This Phase 1/2 study tests PDS01ADC, a targeted cancer drug, for advanced Kaposi sarcoma (KS). It also studies how well the drug works when added to the immunotherapy M7824, especially if KS has not responded to prior treatments.

Bethesda, Maryland
NCT04305691Recruiting· Phase 2
Ixazomib for skin Kaposi sarcoma in people with HIV

This trial studies ixazomib (a targeted anti-cancer medicine) to treat cutaneous (skin) Kaposi sarcoma. It aims to shrink measurable skin lesions and improve symptoms, especially in people living with HIV.

San Diego, California
NCT07308886Recruiting· Phase 2
CYT107 for Kaposi sarcoma in HIV patients with low CD4

This trial tests an experimental drug (CYT107) that boosts the immune system to help fight Kaposi sarcoma in people with HIV who have a low CD4 count despite good HIV treatment. It aims to see if the drug can improve KS tumors and quality of life.

Bethesda, Maryland
NCT06445166Recruiting· Phase 2
Propranolol for Kaposi Sarcoma in adults

This trial tests if the blood pressure medication propranolol can treat Kaposi Sarcoma (a type of skin cancer) in adults. You may be able to join if you have at least 7 measurable skin lesions and are otherwise healthy enough to take an oral pill.

St Louis, Missouri

Hear when a new Kaposi Sarcoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.